Terms: = Liver cancer AND SETD2, ENSG00000181555, 29072 AND Prognosis
4 results:
1. Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib.
Salani F; Latarani M; Casadei-Gardini A; Gangadharannambiar P; Fornaro L; Vivaldi C; Pecora I; Massa V; Marisi G; Canale M; Ulivi P; Scartozzi M; Eccleston M; Masi G; Crea F
Epigenomics; 2022 May; 14(9):507-517. PubMed ID: 35473355
[TBL] [Abstract] [Full Text] [Related]
2. Circular RNA circ SET domain containing 2 (circsetd2) inhibits hepatocellular carcinoma cell proliferation and invasion
Sun K; Zhang L; Chen P; Qi D; Liu H; Bao H; Wang X; Li T
Bioengineered; 2022 Mar; 13(3):7293-7302. PubMed ID: 35260047
[TBL] [Abstract] [Full Text] [Related]
3. setd2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of setd2.
Li H; An J; Wu M; Zheng Q; Gui X; Li T; Pu H; Lu D
Oncotarget; 2015 Sep; 6(29):27847-64. PubMed ID: 26172293
[TBL] [Abstract] [Full Text] [Related]
